Matches in Wikidata for { <http://www.wikidata.org/entity/Q66396020> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q66396020 description "clinical trial" @default.
- Q66396020 description "ensayu clínicu" @default.
- Q66396020 description "klinisch onderzoek" @default.
- Q66396020 description "клінічне випробування" @default.
- Q66396020 name "The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With Inter" @default.
- Q66396020 name "The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With Inter" @default.
- Q66396020 type Item @default.
- Q66396020 label "The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With Inter" @default.
- Q66396020 label "The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With Inter" @default.
- Q66396020 prefLabel "The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With Inter" @default.
- Q66396020 prefLabel "The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With Inter" @default.
- Q66396020 P1050 Q66396020-197F7D58-03B0-48E5-9E00-0B929D40D616 @default.
- Q66396020 P1050 Q66396020-70D015E9-A7BD-4215-8461-323187D8B6F9 @default.
- Q66396020 P1132 Q66396020-D5FE5A90-AA07-41F6-8A26-0921EF1D5975 @default.
- Q66396020 P1476 Q66396020-D29BE494-749E-418B-9911-0CB7C585AE9A @default.
- Q66396020 P17 Q66396020-58E8102B-7281-4AE8-A32C-4515AB9EF7AD @default.
- Q66396020 P1813 Q66396020-1C3B4DF5-1D6C-4627-9750-DC70AFFDDC01 @default.
- Q66396020 P3098 Q66396020-3E454B4E-9C3C-42AA-83A7-0DD9DA60ECF4 @default.
- Q66396020 P31 Q66396020-77161EEB-9F6C-4312-A7C4-6FA16B90A2A5 @default.
- Q66396020 P580 Q66396020-080DD89B-7C33-43D7-BAB6-601672194D46 @default.
- Q66396020 P582 Q66396020-3E5C8574-FFF9-4E7D-8155-5DB244A8DDE3 @default.
- Q66396020 P8363 Q66396020-8C0C2972-104D-4196-845F-4C627DF18AC7 @default.
- Q66396020 P1050 Q179630 @default.
- Q66396020 P1050 Q582207 @default.
- Q66396020 P1132 "+513" @default.
- Q66396020 P1476 "The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International Recommendations" @default.
- Q66396020 P17 Q142 @default.
- Q66396020 P1813 "NOH-ANGIO" @default.
- Q66396020 P3098 "NCT02855047" @default.
- Q66396020 P31 Q30612 @default.
- Q66396020 P580 "2005-07-01T00:00:00Z" @default.
- Q66396020 P582 "2007-09-01T00:00:00Z" @default.
- Q66396020 P8363 Q818574 @default.